Biogen (BIIB) Treasury Shares (2009 - 2026)

Biogen's Treasury Shares history runs 18 years deep, the most recent figure standing at $3.0 billion for Q1 2026.

• In Q1 2026, Treasury Shares changed 0.0% year-over-year to $3.0 billion; the TTM figure through Mar 2026 stood at $3.0 billion (changed 0.0% YoY), while the FY2025 annual figure was $3.0 billion, changed 0.0% from the prior year.
• Treasury Shares was $3.0 billion for Q1 2026 at Biogen, roughly flat from $3.0 billion in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $23.8 million in Q4 2022 to a low of -$23.8 million in Q1 2022.
• Historically, Treasury Shares has averaged -$15.8 million across 5 years, with a median of -$23.8 million in 2022.
• Biggest YoY gain for Treasury Shares was 0.0% in 2022; the steepest drop was 0.0% in 2022.
• A 5-year view of Treasury Shares shows it stood at $3.0 billion in 2022, then changed by 0.0% to $3.0 billion in 2023, then changed by 0.0% to $3.0 billion in 2024, then changed by 0.0% to $3.0 billion in 2025, then changed by 0.0% to $3.0 billion in 2026.
• The last three Treasury Shares figures came in at $3.0 billion (Q1 2026), $3.0 billion (Q4 2025), and $3.0 billion (Q3 2025), per Business Quant data.